Reply to Corona and Cattaneo.
作者信息
Nation Roger L, Garonzik Samira M, Thamlikitkul Visanu, Giamarellos-Bourboulis Evangelos J, Forrest Alan, Paterson David L, Li Jian, Silveira Fernanda P
机构信息
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Australia.
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, State University of New York.
出版信息
Clin Infect Dis. 2017 Sep 1;65(5):870-871. doi: 10.1093/cid/cix390.
Abstract
摘要
相似文献
1
Reply to Corona and Cattaneo.对科罗纳和卡塔内奥的回复。
Clin Infect Dis. 2017 Sep 1;65(5):870-871. doi: 10.1093/cid/cix390.
2
Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration.接受持续静脉-静脉血液透析滤过的危重症患者中多粘菌素甲磺酸盐和多粘菌素的药代动力学
Antimicrob Agents Chemother. 2005 Nov;49(11):4814-5. doi: 10.1128/AAC.49.11.4814-4815.2005.
3
Dosing Colistin Properly: Let's Save "Our Last Resort Old Drug!".合理使用黏菌素：让我们拯救“我们最后的老药”！
Clin Infect Dis. 2017 Sep 1;65(5):870. doi: 10.1093/cid/cix388.
4
Colistin in critically ill patients.多黏菌素在危重症患者中的应用。
Minerva Anestesiol. 2013 Feb;79(2):200-8. Epub 2012 Dec 17.
5
Colistin use in critically ill patients: in search of the optimal dosing.多黏菌素在重症患者中的应用：探寻最佳给药剂量。
Chest. 2011 Jan;139(1):234; author reply 234-5. doi: 10.1378/chest.10-2031.
6
Pharmacokinetic evaluation of colistin sodium.多粘菌素 E 钠的药代动力学评价。
Expert Opin Drug Metab Toxicol. 2011 Feb;7(2):245-55. doi: 10.1517/17425255.2011.541439. Epub 2010 Dec 4.
7
Should We Accept Colistin-Induced Nephrotoxicity To Ensure Attainment of a Therapeutic Steady State in Those with Good Renal Function?对于肾功能良好的患者，我们是否应该接受黏菌素诱导的肾毒性以确保达到治疗稳态？
Antimicrob Agents Chemother. 2018 May 25;62(6). doi: 10.1128/AAC.00351-18. Print 2018 Jun.
8
Colistin penetration in the alveolar lining fluid of critically ill patients treated with IV colistimethate sodium.静脉注射多粘菌素甲磺酸钠治疗的重症患者中多粘菌素在肺泡衬液中的渗透情况。
Chest. 2011 Jan;139(1):232-3; author reply 233-4. doi: 10.1378/chest.10-1860.
9
Dose of colistin: a work in progress?黏菌素剂量：一项正在进行的工作？
Crit Care. 2015 Feb 16;19(1):65. doi: 10.1186/s13054-015-0743-x.
10
Removal of colistin during intermittent haemodialysis in two critically ill patients.两名重症患者在间歇性血液透析期间黏菌素的清除情况。
J Antimicrob Chemother. 2010 Aug;65(8):1836-7. doi: 10.1093/jac/dkq185. Epub 2010 May 25.
引用本文的文献
1
Polymyxin Acute Kidney Injury: Dosing and Other Strategies to Reduce Toxicity.多粘菌素所致急性肾损伤：给药及其他降低毒性的策略
Antibiotics (Basel). 2019 Mar 14;8(1):24. doi: 10.3390/antibiotics8010024.
2
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment.低蛋白血症作为黏菌素治疗期间急性肾损伤的预测因子。
Sci Rep. 2018 Aug 10;8(1):11968. doi: 10.1038/s41598-018-30361-5.
本文引用的文献
1
Dosing Colistin Properly: Let's Save "Our Last Resort Old Drug!".合理使用黏菌素：让我们拯救“我们最后的老药”！
Clin Infect Dis. 2017 Sep 1;65(5):870. doi: 10.1093/cid/cix388.
2
Dosing guidance for intravenous colistin in critically-ill patients.危重症患者静脉注射黏菌素的剂量指南。
Clin Infect Dis. 2017 Mar 1;64(5):565-571. doi: 10.1093/cid/ciw839. Epub 2016 Dec 23.
3
Challenge for higher colistin dosage in critically ill patients receiving continuous venovenous haemodiafiltration.危重症患者行连续性静脉-静脉血液透析滤过治疗时，面临更高黏菌素剂量的挑战。
Int J Antimicrob Agents. 2016 Sep;48(3):337-41. doi: 10.1016/j.ijantimicag.2016.06.008. Epub 2016 Jul 18.
4
Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?美国和欧洲更新的静脉注射多粘菌素剂量建议：它们的效果如何？
Clin Infect Dis. 2016 Mar 1;62(5):552-558. doi: 10.1093/cid/civ964. Epub 2015 Nov 25.
5
Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.在重症患者中应用9MU多粘菌素甲磺酸盐负荷剂量后的多粘菌素群体药代动力学。
Antimicrob Agents Chemother. 2015 Dec;59(12):7240-8. doi: 10.1128/AAC.00554-15. Epub 2015 Sep 14.
6
Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations.在某些危重症患者中初始β-内酰胺类药物浓度低于治疗范围：增强的肾脏清除率与低药物谷浓度之间的关系。
Chest. 2012 Jul;142(1):30-39. doi: 10.1378/chest.11-1671.
7
Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients.多中心研究中重症患者的黏菌素甲磺酸盐和形成的黏菌素群体药代动力学为各类患者提供了给药建议。
Antimicrob Agents Chemother. 2011 Jul;55(7):3284-94. doi: 10.1128/AAC.01733-10. Epub 2011 May 9.
Zotero 插件